In the current market health budgets (both public and private) are coming under ever more pressure and increasing requirement for formal and informal tenders. As a result, our clients regularly seek advice in relation to challenging and complex market access and tendering issues.

We have experience advising in relation to reimbursement environment and market access. This includes drafting submissions in support of applications for NICE approval, negotiating risk sharing agreements, and challenging refusals to allow reimbursement for a particular medicine or medical device.

See also:
Pharmaceuticals
Medical Technologies
Cell-Based Therapies and ATMPs
Commercial Law